You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GALT Sale Disclosure
Jamil Khurram · SEC Form 4 · Filed Jul 16, 2026
Sale
Calculated transaction value
$83.28K
Jamil Khurram Chief Medical Officer
GALT
Transaction date
Jul 14, 2026
Public filing date
Jul 16, 2026
Filing lag
Filed 2 days later
GALT daily price context
Close on/before transaction
$5.34
Jul 14, 2026
First close after public filing
$4.17
Jul 17, 2026
30-day return after filing
-15.93%
Through Aug 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 16,250 shares @ $5.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001133416-26-000063
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$132.68K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Galectin Therapeutics Inc GALT | Exercise | Jul 14, 2026 | $49.4K |
| Galectin Therapeutics Inc GALT Current | Sale | Jul 14, 2026 | $83.28K |
| Galectin Therapeutics Inc GALT | Exercise | Jul 14, 2026 | $0 |